P. Hayry

发表

The Banff 97 working classification of renal allograft pathology.

H. E. Hansen, P. Nickerson, D. Rush, 1999, Kidney international.

Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

M. Fishbein, R. Colvin, M. Mihatsch, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Estrogen receptor beta dominates in baboon carotid after endothelial denudation injury

P. Hayry, E. Aavik, J. Frösen, 2001, Molecular and Cellular Endocrinology.

Mechanisms behind the Synergistic Effect of Sirolimus and Imatinib in Preventing Restenosis after Intimal Injury

P. Hayry, E. Aavik, H. Savolainen-Peltonen, 2008, Journal of Vascular Research.

HISTOLOGICAL CHRONIC ALLOGRAFT DAMAGE INDEX ACCURATELY PREDICTS CHRONIC RENAL ALLOGRAFT REJECTION

H. Isoniemi, P. Hayry, E. Taskinen, 1994, Transplantation.

A peptide mimic of selectin ligands abolishes in vivo inflammation but has no effect on the rat heart allograft survival1

T. Paavonen, P. Hayry, R. Renkonen, 2002, Transplantation.

Major histocompatibility complex protein expression on pancreas and pancreatic islet endocrine cell subsets.

M. Charles, P. Hayry, E. Taskinen, 1989, The American journal of pathology.

Growth factors and receptors in allograft arteriosclerosis.

M. Brink, P. Hayry, P. Delafontaine, 1999, Transplantation proceedings.

Method for Chromosome Preparation from Mouse Peripheral Lymphocytes 1

P. Hayry, V. Defendi, M. Virolainen, 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

ANTAGONISTIC EFFECTS OF y INTERFERON AND STEROIDS ON TISSUE ANTIGENICITY

Dariusz, Schellekens, P. Hayry, 2003 .

Vasculoprotective effects of somatostatin receptor subtypes

P. Hayry, E. Aavik, H. Savolainen-Peltonen, 2007, Molecular and Cellular Endocrinology.

Elimination of vascular fibrointimal hyperplasia bysomatostatin receptor 1.4 selective agonist

P. Hayry, E. Aavik, Y. Patel, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs.

M. Mihatsch, P. Hayry, B. Fellström, 1993, Transplantation proceedings.

Banff schema for grading liver allograft rejection: An international consensus document

Randall G. Lee, K. Batts, R. Wiesner, 1997, Hepatology.

Allograft Immunity In Vitro

L. Andersson, S. Nordling, P. Hayry, 1973, Scandinavian journal of immunology.

Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty

P. Hayry, U. Kumar, Y. Patel, 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity

P. Hayry, B. Husberg, A. Nemlander, 1982, The Journal of experimental medicine.

Correlation between gene expression and morphological alterations in baboon carotid after balloon dilatation injury

J. Boldrick, M. Sarwal, Christopher Barry, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Glucocorticosteroids in Renal Transplantation

P. Hayry, S. Koskimies, B. Eklund, 1984, Scandinavian journal of immunology.

Functional significance of the Fc receptor on mixed lymphocyte culture-activated T blasts.

L. Andersson, P. Hayry, 1976, Cellular immunology.

Estrogens and octapeptides in rejection

P. Hayry, P. Ramwell, M. Foegh, 1999 .

Bone Marrow Transplantation intheRat III. Structure of theLiver Infammatory Lesion inAcute Graft-Versus-Host Disease

P. Hayry, 1985 .

Brush Border Enzymes in Evaluation of Acute Small Bowel Rejection

T. Paavonen, E. Savilahti, M. Pakarinen, 1996, Scandinavian journal of immunology.

Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for Long-Term graft survival.

T. Paavonen, M. Navarro, P. Hayry, 2004, Transplantation proceedings.